Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study

Autor: Ruben A. Mesa, Claire Harrison, Jeanne M. Palmer, Vikas Gupta, Donal P. McLornan, Mary Frances McMullin, Jean-Jacques Kiladjian, Lynda Foltz, Uwe Platzbecker, Maria Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Charles Perkins, Michael F. Leahy, Jun Kawashima, Sunhee Ro, Rafe Donahue, Boris Gorsh, Samineh Deheshi, Srdan Verstovsek

Publikováno v: HemaSphere, Vol 7, Iss 11, p e966 (2023)

Myelofibrosis (MF) is a chronic myeloproliferative neoplasm that typically manifests with debilitating symptoms that progressively worsen, negatively impacting patients’ quality of life. Fatigue is a multifactorial and burdensome MF-related symptom

Externí odkaz: https://doaj.org/article/f9632edb1b7c4fa09e09d3f5fe8a8134

Mitochondrial trafficking in neuropsychiatric diseases

Autor: Samineh Deheshi, Bryce A. Pasqualotto, Gordon L. Rintoul

Publikováno v: Neurobiology of Disease, Vol 51, Iss , Pp 66-71 (2013)

Mitochondria have numerous roles in healthy neuronal functioning and in neuronal injury mechanisms. They are quite dynamic organelles in that they fuse, divide and move throughout axons and dendrites. The mechanisms of mitochondrial motility have rec

Externí odkaz: https://doaj.org/article/5faeeee57d7a4fa3ae63d0eed38b5862

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy

Autor: Carolyn Ch'ng, Samineh Deheshi, Alejandro Berlin, Theodorus van der Kwast, Melania Pintilie, Suzanne Kamel-Reid, Elai Davicioni, Jure Murgic, Jingbin Zhang, Adriana Salcedo, Qiqi Wang, Robert G. Bristow, Melvin L.K. Chua, Michael Fraser, Paul C. Boutros, Ali Hosni

Publikováno v: Berlin, A, Murgic, J, Hosni, A, Pintilie, M, Salcedo, A, Fraser, M, Kamel-Reid, S, Zhang, J, Wang, Q, Ch'ng, C, Deheshi, S, Davicioni, E, van der Kwast, T, Boutros, P C, Bristow, R G & Chua, M L K 2018, ' Genomic classifier for guiding treatment of intermediate-risk prostate cancers to dose-escalated image-guided radiotherapy without hormone therapy ', International journal of radiation oncology, biology, physics . https://doi.org/10.1016/j.ijrobp.2018.08.030

Purpose The National Comprehensive Cancer Network (NCCN) has recently endorsed the stratification of intermediate-risk prostate cancer (IR-PCa) into favorable and unfavorable subgroups and recommend the addition of androgen deprivation therapy (ADT)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3238a7e6a7c8acc8dd33fefa0e6b91
https://doi.org/10.1016/j.ijrobp.2018.08.030

Poster: MPN-303: Longitudinal and Individual Symptom Analyses from the SIMPLIFY-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor-Naive Myelofibrosis Patients

Autor: Rafe Donahue, Srdan Verstovsek, David M. Ross, Adam J. Mead, Stephen T. Oh, Lynda Foltz, Vikas Gupta, Samineh Deheshi, Stacie Hudgens, Maria Laura Fox, Andrew C. Perkins, Jeanne Palmer, Michael F. Leahy, Uwe Platzbecker, Ruben A. Mesa, Mary Frances McMullin, Lysbeth Floden, Barbara Klencke, Jean-Jacques Kiladjian, Donal P. McLornan

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S231

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::047b4ef563521ce02facc327e11f5dde
https://doi.org/10.1016/s2152-2650(21)01455-5

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

Autor: Tyler Kolisnik, Elai Davicioni, John W. Davis, Tamara L. Lotan, Neil E. Martin, Paul L. Nguyen, Sanoj Punnen, Eric A. Klein, Ashley E. Ross, Daniel E. Spratt, Radka Stoyanova, Felix Y. Feng, Alan Pollack, Christine Buerki, Kaye Ong, Samineh Deheshi, Jijumon Chelliserry, Zaid Haddad, Voleak Choeurng, Kasra Yousefi, Maria Aranes, Lucia L.C. Lam, Christopher J. Kane, Jeffrey J. Tosoian, Bruce J. Trock, Jennifer Margrave

Publikováno v: European Urology. 72:845-852

Background Decipher is a validated genomic classifier developed to determine the biological potential for metastasis after radical prostatectomy (RP). Objective To evaluate the ability of biopsy Decipher to predict metastasis and Prostate cancer-spec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5113292bea7b5992974f89be4d29e441
https://doi.org/10.1016/j.eururo.2017.05.009